drugset / Trial / NCT01253694
Ranibizumab as a Rescue Therapy for Diabetic Macular Edema
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Treatment with Ranibizumab of the residual diabetic edema in patients with failed response to Bevacizumab.
Timeline
- Start
- 2011-03
- Primary completion
- 2012-06
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |